The use of patient-reported outcomes to detect adverse events in metastatic melanoma patients receiving immunotherapy: a randomized controlled pilot trial

The use of patient-reported outcomes to detect adverse events in metastatic melanoma patients receiving immunotherapy: a randomized controlled pilot trial

Abstract Background A randomized controlled pilot trial was conducted to assess if melanoma patients treated with immunotherapy had the number of grade 3 or 4 adverse events during treatment reduced by 50% using a tailored electronic patient-reported outcomes tool in addition to standard toxicity mo...

Full description

Bibliographic Details
Main Authors: Lærke K. Tolstrup, Lars Bastholt, Karin B. Dieperink, Sören Möller, Ann-Dorthe Zwisler, Helle Pappot
Format: Article
Language:English
Published: SpringerOpen 2020-10-01
Series:Journal of Patient-Reported Outcomes
Subjects:
RCT
Patient-reported outcomes
PRO
Melanoma
Adverse events
Toxicity
Online Access:http://link.springer.com/article/10.1186/s41687-020-00255-0

Internet

http://link.springer.com/article/10.1186/s41687-020-00255-0

Similar Items